Our findings demonstrate S100A2 might be responsible for the preservation of immune-suppressive status in PC microenvironment, which contributes to accurate assessment of the prognosis of PC patients and optimization of the clinical decision-making. The gene discussed is S100A2; the disease is pachyonychia congenita.